GRALMID

GRAIL, Inc.

HealthcareMedical - Diagnostics & Research
$62.75
$0.10(+15.35%)
52W$29.95
$118.84
Updated May 7, 12:00 AM
RSI53
RS Rating42/99
Beta2.70
Volatility106%
F-Score5/9
Mkt Cap$2.6B
CONSOLIDATING

Price Action

5Y Daily
50 DMA150 DMA200 DMA

Technical Summary

CONSOLIDATING

GRAIL, Inc. is in a consolidation phase, trading with mixed signals as moving averages converge. Relative strength is weak (RS Rating: 42), showing significant lag compared to the market leaders. Earnings growth of 16% provides fundamental context to the price action. However, price is extended 23% above the 50-day line, increasing the risk of a mean reversion.

Relative Strength
42
out of 99
Lagging
Trend Score
2/4
Minervini Criteria
CONSOLIDATING
Risk (Beta)
2.70
vs S&P 500
HIGH BETA
52W Position
37%
from 52W low
Lower Half
Trend & Momentum Analysis

Trend Template (Minervini)

CONSOLIDATING2/4 Criteria Met
CriterionValueStatus
Price > 50 SMA$50.88
50 SMA > 100 SMA$72.83
100 SMA > 150 SMA$77.04
150 SMA > 200 SMA$67.11

Price vs Moving Averages

PeriodValueSpreadSignal
20 SMA$52.04+20.57%ABOVE
50 SMA$50.88+23.33%ABOVE
100 SMA$72.83-13.84%BELOW
150 SMA$77.04-18.54%BELOW
200 SMA$67.11-6.50%BELOW

Price Performance

1D+15.3%
1W+26.3%
1M+21.3%
3M-37.3%
6M-21.6%
YTD-29.4%
1Y+95.1%
3Y+66.2%
52-Week Trading Range37% from low
$62.75
52W Low$29.95
52W High$118.84

Technical Indicators

RSI (14)NEUTRAL
52.9
305070
VCP ScoreCOOL
3/10
Base depth: 106.8%

Risk Profile

Beta
2.70
52W Vol
106%
ATR
$3.09
Max DD (1Y)
-63%

Volume Analysis

Today
1.25M
50D Avg
860.2K
Vol Ratio
1.46x
Liquidity
MODERATE

Earnings Momentum

Q1'25+56%
$-3.10
Q2'25+94%
$-3.18
Q3'25+38%
$-2.46
Q4'25+16%
$-2.44
Fundamentals & Growth

Growth Trends

Compounded Sales Growth

10 Years:
5 Years:
3 Years:+38.37%
TTM:+17.18%

Compounded Profit Growth

10 Years:
5 Years:
3 Years:
TTM:+82.78%

Stock Price CAGR

10 Years:+16.47%
5 Years:+35.65%
3 Years:+66.23%
1 Year:+95.12%

Return on Equity

10Y Avg:-45.5%
5Y Avg:-43.8%
3Y Avg:-39.1%
Last Year:-17.1%

Key Metrics

Market Cap$2.6B
Gross Margin-42.5%
Net Margin-2.8%
Piotroski F-Score5/9

Frequently Asked Questions

Is GRAL in an uptrend right now?

GRAL has a trend score of 2/4 based on Minervini's Stage Analysis. Currently showing partial alignment - 2 of 4 trend criteria are met.

Is GRAL overbought or oversold?

GRAL's RSI (14) is 53. The stock is in neutral territory, neither overbought nor oversold.

Is GRAL outperforming the market?

GRAL has a Relative Strength (RS) Rating of 42 out of 99. GRAL is currently lagging the broader market.

Where is GRAL in its 52-week range?

GRAL is trading at $62.75, which is 53% of its 52-week high ($118.84) and 37% above its 52-week low ($29.95).

How volatile is GRAL?

GRAL has a Beta of 2.70 and 52-week volatility of 106%. It's more volatile than the S&P 500 - expect bigger swings.

Disclaimer: Data is for informational purposes only. May be delayed or contain errors. Past performance does not guarantee future results. This is not financial advice. Always conduct your own research and consult professionals before making investment decisions.